Therapeutics: MAP kinase 1 (MAPK1; ERK-2)

In vitro and mouse studies identified an inhibitor of cytoplasmic MAPK1 dimerization that could help treat cancer. A protein electrophoresis-based screen of 1,100 small molecules identified a compound...